Akcea Therapeutics, a majority owned affiliate of Ionis Pharmaceuticals, announced positive topline results from the Phase 2 study of AKCEA-APOCIII-LRx in the treatment of patients with hypertriglyceridemia who are at risk for or have established cardiovascular...
According to Dr. Irving Kent Loh, chief medical officer and co-founder of Infermedica, an artificial intelligence in healthcare company focused on clinical decision support, the future of healthcare is headed for vast changes in the next decade. Dr. Loh, a...
Some European doctors recently backed away from the findings of a major study that found bypass surgery and stents are equally effective at preventing heart disease deaths when a major heart artery is clogged. There has been growing preference for stents as they allow...
A Mayo Clinic-led research team has concluded that the presence of comorbidities, such as inflammatory bowel disease, type 1 diabetes, venous thromboembolism, cardiovascular disease and obstructive sleep apnea may either predispose patients to rheumatoid arthritis...
Preventive cardiology researchers at UT Southwestern Medical Center have been on a mission to look for new ways to detect early stage heart disease in people who are not currently in treatment. They now believe that a new blood test for protein biomarkers could...
The North American Menopause Society (NAMS) completed the VITamin D and OmegA-3 Trial (VITAL)., the largest and most recent test to investigate Vitamin D or fish oil can effectively prevent cancer or cardiovascular disease. Results have been generally mixed however in...
